- Publication: Dacoba T. G., Anthiya S., Berrecoso G., Fernández-Mariño I., Fernández-Varela C., Crecente-Campo J., Teijeiro-Osorio D., Torres-Andón F., Alonso M.J., Nano‐Oncologicals: A Tortoise Trail Reaching New Avenues, Adv. Funct. Mater., 2009860 (1-36) (2021)
https://doi.org/10.1002/adfm.202009860
Nanotechnology is now opening new avenues for the treatment of cancer. Here we present a critical view on the potential of nanotechnology to improve the delivery of drugs (small molecules, monoclonal antibodies and RNA-based therapies) to tumor cells or to the tumor microenvironment. We foresee a future where the therapeutic strategy can be thoughtfully designed taking into account the tumor type, the immune status of the patient, and the nature of the active molecule. This is the era of personalized nanomedicine.
